शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
INDRAMEDCONSEIndraprastha Medical Corporation Limited· Healthcare ServicesHighPositive
Announced Wed, 6 Aug, 2025 · 17:37 IST

Indraprastha Medical Corporation Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 18-Sep-2025.

INDRAMEDCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.5%Reaction day
₹445.00
prior close
₹458.95
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+4.8% vs market
Hospital peers, median of 21sector-0.1%+4.6% vs sector

On the reaction day the stock moved 4.8 pts more than Nifty Microcap 250 and 4.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.2
10m
+5.7
15m
+5.1
30m
+4.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.5-0.3+4.8-0.1+4.6
Next day
+0.9-1.2+2.0-1.1+2.0
2d
+4.6-1.0+5.6-0.7+5.3
3d
+5.1-1.0+6.1+1.4+3.8
4d
+5.1-0.3+5.4+2.3+2.8
5d
+2.3-1.1+3.4+1.6+0.8
1w
+5.1+1.6+3.4+1.8+3.2
15d
+0.2-0.2+0.4-0.8+1.0
1m
+7.7+1.4+6.3+0.4+7.3
2m
+28.9+0.2+28.7+1.5+27.4
3m
+39.6+0.9+38.7+4.6+34.9
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) reported its Q1 FY26 (quarter ended 30 June 2025) unaudited results. Revenue from operations rose to Rs 365.06 crore from Rs 347.86 crore a year ago, while profit after tax grew about 15% to Rs 51.46 crore (vs Rs 44.77 crore), pushing EPS to Rs 5.61 from Rs 4.88. The Board fixed 18 September 2025 as the record date to identify shareholders eligible for the FY25 dividend and to attend the AGM. The 37th AGM is scheduled for 24 September 2025 via video conferencing. In other decisions, Mr. Sudhir Jalan was appointed as Independent Director for 5 years, Cost Auditors were re-appointed, and M/s RSM & Co. was appointed as Secretarial Auditors for FY26–FY30.

Likely market impact

Steady top-line growth and a sharp rise in profit suggest healthy hospital operations heading into FY26. The record date announcement confirms a FY25 dividend is on the way; investors must hold shares by 18 September 2025 to qualify. Director and auditor appointments are routine governance matters with no immediate price impact.